Over $198 billion in global prescription drug sales are at risk between 2019-2024 from patent expirations, according to a new report from EvaluatePharma. Experts are now warning that the pharmaceutical industry is on the brink of a second patent cliff. Worldwide prescription drug sales are expected to grow at a CAGR of 6.9 percent to $842…
North America Projected to Generate $635 Billion in Pharmaceutical Sales by 2022
North America is expected to continue to lead global pharmaceutical sales in the year 2022, with $635 billion expected that year, according to a March 2019 report from biopharmaceutical company AstraZeneca. The United States, China, Japan, Germany and France led the world pharmaceutical sales market in 2018, with the United States having 47.2 percent of…
